These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4415183)

  • 1. Present status of clinical pharmacology and of regulatory requirements for preclinical and clinical evaluation of new drugs in Japan.
    Ishizaki T; Sugita M
    Clin Pharmacol Ther; 1974 Sep; 16(3):577-84. PubMed ID: 4415183
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology in the United Kingdom.
    Smith RN
    Clin Pharmacol Ther; 1974 Sep; 16(3):605-15. PubMed ID: 4412474
    [No Abstract]   [Full Text] [Related]  

  • 3. Present status of clinical pharmacology in Italy.
    Sirtori C
    Clin Pharmacol Ther; 1974 Sep; 16(3):572-6. PubMed ID: 4415184
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical pharmacology in Australia.
    Nixon PF
    Clin Pharmacol Ther; 1974 Sep; 16(3):545-53. PubMed ID: 4412475
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacological evaluation in drug control.
    Friebel H
    Eur J Clin Pharmacol; 1973 Jun; 6(1):69-73. PubMed ID: 4764374
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology in Ireland.
    Bourke E
    Clin Pharmacol Ther; 1974 Sep; 16(3):568-71. PubMed ID: 4412477
    [No Abstract]   [Full Text] [Related]  

  • 7. Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
    Cahal DA
    Can Med Assoc J; 1968 Feb; 98(6):271-5. PubMed ID: 5636096
    [No Abstract]   [Full Text] [Related]  

  • 8. Industrial research in the quest for new medicines.
    Berde B
    Clin Exp Pharmacol Physiol; 1974; 1(3):183-95. PubMed ID: 4617642
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimum acceptable requirements for introduction and marketing of drugs.
    Lasagna L
    Drugs; 1974; 7(6):409-13. PubMed ID: 4422210
    [No Abstract]   [Full Text] [Related]  

  • 10. [The admission of drugs in the Netherlands].
    ten Ham M
    Ned Tijdschr Geneeskd; 1983 May; 127(22):968-71. PubMed ID: 6866153
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulatory differences and similarities: systems in Japan.
    Sakuma A
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):694-9. PubMed ID: 1269210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems in the organization of clinical pharmacology in Denmark.
    Hvidberg EF
    Clin Pharmacol Ther; 1974 Sep; 16(3):565-7. PubMed ID: 4415213
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the West German drug law upon development of clinical pharmacology.
    Kampffmeyer H
    Clin Pharmacol Ther; 1974 Sep; 16(3):616-9. PubMed ID: 4413783
    [No Abstract]   [Full Text] [Related]  

  • 15. An overview from the United States.
    Besselaar GH; Tempero KF
    Clin Pharmacol Ther; 1974 Sep; 16(3):620-4. PubMed ID: 4411989
    [No Abstract]   [Full Text] [Related]  

  • 16. [Responsibility for drug reactions].
    Naess K
    Nord Med; 1975 Mar; 90(3):65-6. PubMed ID: 1153254
    [No Abstract]   [Full Text] [Related]  

  • 17. Report of the Subcommittee on Inhalation Toxicology of the Department of Health, Education and Welfare Committee to Coordinate Toxicology and Related Programs.
    J Environ Pathol Toxicol; 1977; 1(2):353-81. PubMed ID: 553140
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacology in Canada.
    Sellers EM
    Clin Pharmacol Ther; 1974 Sep; 16(3):554-64. PubMed ID: 4412476
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic implications of the drug lag.
    Wardell WM
    Clin Pharmacol Ther; 1974 Jan; 15(1):73-96. PubMed ID: 4150345
    [No Abstract]   [Full Text] [Related]  

  • 20. Requirements to be fulfilled before instituting clinical trials on new drugs.
    Griffin JP
    Proc R Soc Med; 1974 Jun; 67(7):581-4. PubMed ID: 4605052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.